Oxford Finance LLC logo

Oxford Finance LLC

North America, Virginia, United States, Alexandria

Description

Oxford Finance delivers flexible financial solutions to healthcare and life sciences companies worldwide.

Investor Profile

Oxford Finance LLC has made 154 investments, with 2 in the past 12 months and 45% as lead.

Stage Focus

  • Debt Financing (55%)
  • Post Ipo Debt (36%)
  • Series Unknown (4%)
  • Series B (2%)
  • Post Ipo Equity (1%)
  • Series C (1%)
  • Series E (1%)
  • Series A (1%)

Country Focus

  • United States (92%)
  • United Kingdom (4%)
  • Ireland (1%)
  • Canada (1%)
  • The Netherlands (1%)
  • Switzerland (1%)
  • Germany (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Pharmaceutical
  • Therapeutics
  • Health Diagnostics
  • Biopharma
  • Life Science
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Oxford Finance LLC frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 2
Domain Associates
North America, California, United States, San Diego
Co-Investments: 2
East West Bank
North America, California, United States, Pasadena
Co-Investments: 3
Square 1 Bank
North America, North Carolina, United States, Durham
Co-Investments: 4
GE Capital
North America, Ontario, Canada, Ottawa
Co-Investments: 2
Scale Venture Partners
North America, California, United States, Foster City
Co-Investments: 2
Silicon Valley Bank
North America, California, United States, Santa Clara
Co-Investments: 46
Armentum Partners
North America, California, United States, San Francisco
Co-Investments: 3
Clarus Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
MidCap Financial
North America, Maryland, United States, Bethesda
Co-Investments: 4

What are some of recent deals done by Oxford Finance LLC?

Inhibrx

La Jolla, California, United States

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

BiotechnologyLife ScienceTherapeutics
Post Ipo DebtJan 13, 2025
Amount Raised: $150,000,000
Soleno Therapeutics

Redwood City, California, United States

Soleno Therapeutics is a clinical-stage biopharmaceutical company.

BiotechnologyMedicalPharmaceutical
Post Ipo DebtDec 17, 2024
Amount Raised: $50,000,000
Verona Pharma

London, England, United Kingdom

Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.

BiotechnologyPharmaceuticalTherapeutics
Post Ipo DebtJan 2, 2024
Amount Raised: $400,000,000
Headspace

Santa Monica, California, United States

Headspace specializes in providing mental healthcare, including coaching therapy and psychiatry, as well as meditation mindfulness tools.

FitnessHealth CareInternetMedicalMental HealthmHealthMobile AppsTherapeutics
Debt FinancingJul 26, 2023
Amount Raised: $105,000,000
Amino

San Francisco, California, United States

Amino is a data-driven healthcare guidance platform that helps companies and their employees navigate the complex US healthcare system.

Employee BenefitsFinancial ServicesHealth CareWellness
Debt FinancingMay 11, 2023
Amount Raised: $42,000,000
Pearl Street Dental Management

Dallas, Texas, United States

Pearl Street Dental provides succession plans for retiring dentists and supports non-clinical operations.

FinanceHuman ResourcesManagement Consulting
Debt FinancingNov 16, 2022
Amount Raised: $115,000,000
Renibus Therapeutics

Southlake, Texas, United States

Renibus Therapeutics is a clinical-stage biotech company that focuses on preventing and treating kidney disease.

BiotechnologyHealth CareTherapeutics
Debt FinancingNov 14, 2022
Amount Raised: $10,000,000
ALX Oncology

San Francisco, California, United States

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

BiopharmaBiotechnologyHealth CareLife ScienceOncologyTherapeutics
Post Ipo DebtOct 31, 2022
Amount Raised: $100,000,000
Verona Pharma

London, England, United Kingdom

Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.

BiotechnologyPharmaceuticalTherapeutics
Post Ipo DebtOct 17, 2022
Amount Raised: $150,000,000
Antheia

Menlo Park, California, United States

A synthetic biology company for next generation plant-inspired medicines

BiotechnologyHealth CareManufacturing
Debt FinancingJun 22, 2022
Amount Raised: $40,000,000